QDEL (QuidelOrtho) Marketable Securities: $0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QDEL QuidelOrtho Corp QDEL
43 GF Score
Price $16.05
GF Value $37.37
Valuation Possible Value Trap
! 8 Warning Signs
View Full Analysis

What is QuidelOrtho Marketable Securities?

QuidelOrtho QDEL -3.17% 43 Marketable Securities is $0 Mil as of Mar. 2026. GuruFocus rates QDEL with a GF Score™ of 43/100 and a GF Value™ of $37.37 (Possible Value Trap). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. QuidelOrtho's Marketable Securities for the quarter that ended in Mar. 2026 was $0 Mil.

QuidelOrtho's annual Marketable Securities declined from Dec. 2023 ($48 Mil) to Dec. 2024 ($0 Mil) but then stayed the same from Dec. 2024 ($0 Mil) to Dec. 2025 ($0 Mil).

QuidelOrtho  (NAS:QDEL) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

QuidelOrtho Marketable Securities Related Terms

QuidelOrtho Marketable Securities Historical Data

* Premium members only.

The historical data trend for QuidelOrtho's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

QuidelOrtho Marketable Securities Chart

QuidelOrtho Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.70 52.10 48.40 0.00 0.00

QuidelOrtho Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
QDEL
43GF Score
QuidelOrtho Corp QDEL
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QuidelOrtho Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0 Mil mean?
QuidelOrtho (QDEL) has a Marketable Securities of $0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on QuidelOrtho and its competitors.
Is QuidelOrtho's Marketable Securities too high?
QuidelOrtho's current Marketable Securities is $0 Mil. Overall, QuidelOrtho has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does QuidelOrtho's Marketable Securities compare to AVR and INMD?
QuidelOrtho's Marketable Securities of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on QuidelOrtho and its competitors. QuidelOrtho's current Marketable Securities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QuidelOrtho stock overvalued right now?
Based on GuruFocus' analysis, QuidelOrtho (QDEL) is currently considered Possible Value Trap. The stock's GF Value™ is $37.37, compared to a current price of $16.05 — trading 57.1% below its estimated fair value. The current Marketable Securities is $0 Mil. QuidelOrtho's overall GF Score™ is 43/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For QuidelOrtho (QDEL), the current Marketable Securities is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is QuidelOrtho (QDEL) Overvalued in 2026?

Based on GuruFocus' analysis, QuidelOrtho stock appears to be undervalued. The current stock price of $16.05 is trading 57.1% below its estimated GF Value™ of $37.37. GuruFocus considers QuidelOrtho to be Possible Value Trap.

Key valuation signals for QDEL:

  • Marketable Securities: $0 Mil
  • GF Value™: $37.37 vs. price of $16.05 (57.1% below fair value)
  • GF Score™: 43/100 with 8 warning signs

No single metric tells the full story. See the QDEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

QuidelOrtho Business Description

Other Exchanges 0A55:UKQL1A:Germany
Address 9975 Summers Ridge Road, San Diego, CA, USA, 92121
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
43GF Score

Get the complete analysis for QDEL

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.05
Price
$37.37
GF Value